Dimitrios Mougiakakos

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

Andréas Mackensen, Fabian Müller, Dimitrios Mougiakakos et al. · Nature Medicine · 2022 · 999 citations

Life Sciences, Hematology, Immunology +14

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer

Angela M. Krebs, Julia Mitschke, M Losada et al. · Nature Cell Biology · 2017 · 985 citations · Full text

Medicine, Cell Biology, Oncology +16

CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

Fabian Müller, Jule Taubmann, Laura Bucci et al. · New England Journal of Medicine · 2024 · 948 citations

Life Sciences, Clinical Sciences, Immunology +17

Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss

Sébastien Lucas, Yasunori Omata, Jörg Hofmann et al. · Nature Communications · 2017 · 750 citations · Full text

Medicine, Immunology, Nutritional Sciences +17

CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

Kai Rejeski, Ariel Perez Perez, Pierre Sesques et al. · Blood · 2021 · 441 citations · Full text

Life Sciences, Hematology, Immunology +16